Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C.

about

Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C.

Item

http://www.wikidata.org/entity/Q40141719

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effectiveness of Ledipasvir/So ...... t Recipients with Hepatitis C.

@en

type

Item

label

Effectiveness of Ledipasvir/So ...... t Recipients with Hepatitis C.

@en

prefLabel

Effectiveness of Ledipasvir/So ...... t Recipients with Hepatitis C.

@en

P1476

Effectiveness of Ledipasvir/So ...... t Recipients with Hepatitis C.

@en

P2093

Caterina A Kachadoorian

http://www.w3.org/2001/XMLSchema#string

Francisco A Durazo

http://www.w3.org/2001/XMLSchema#string

Gina Choi

http://www.w3.org/2001/XMLSchema#string

Jonathan Grotts

http://www.w3.org/2001/XMLSchema#string

Justin Rheem

http://www.w3.org/2001/XMLSchema#string

Melissa A Jimenez

http://www.w3.org/2001/XMLSchema#string

Michelle H Mai

http://www.w3.org/2001/XMLSchema#string

Mohammed M El-Kabany

http://www.w3.org/2001/XMLSchema#string

Negin L Esmailzadeh

http://www.w3.org/2001/XMLSchema#string

Samantha D Ramirez

http://www.w3.org/2001/XMLSchema#string

P2860

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients

OPTN/SRTR 2013 Annual Data Report: liver.

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.

Viekira Pak (Ombitasvir, Paritaprevir, and Ritonavir Tablets; Dasabuvir Tablets): All-Oral Fixed Combination Approved for Genotype 1 Chronic Hepatitis C Infection

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort.

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.

P304

101-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14218/JCTH.2016.00070

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ronald W Busuttil

P577

2017-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28660147

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

P932

5472930

http://www.w3.org/2001/XMLSchema#string